Download PDF
J Neurol Surg B Skull Base 2019; 80(05): 505-510
DOI: 10.1055/s-0038-1675558
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Bioabsorbable Steroid Eluting Stents in the Treatment of Recurrent Rathke's Cleft Cyst

Elisabeth H. Ference
1   Rick and Tina Caruso Department of Otolaryngology–Head and Neck Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States
,
Karam W. Badran
2   Department of Otolaryngology–Head and Neck Surgery, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, United States
,
Edward C. Kuan
3   Department of Otorhinolaryngology–Head and Neck Surgery, University of California, Irvine Medical Center, Orange, California, United States
,
Marvin Bergsneider
4   Department of Neurosurgery, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States
,
Anthony P. Heaney
5   Department of Endocrinology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States
,
Marilene B. Wang
2   Department of Otolaryngology–Head and Neck Surgery, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, United States
› Author Affiliations
Further Information

Publication History

19 February 2018

27 September 2018

Publication Date:
06 December 2018 (online)

    Permissions and Reprints

Abstract

Objectives Bioabsorbable steroid eluting stents may prevent the stenosis of ostia after sinus surgery. We describe a technique utilizing this technology to prevent the reformation of Rathke's cleft cysts (RCC) after transnasal transsphenoidal surgical drainage.

Design This study is based on retrospective review.

Setting The research took place at Tertiary academic medical center.

Participants Patients who underwent endoscopic marsupialization of RCC with stent placement were participated in this study.

Main Outcome Measures Demographics, surgical history, outcomes, and complications were primary measures of this study.

Results Four patients underwent drainage of a recurrent RCC with subsequent stent placement. All patients consented to off-label use of the stent. The mean age of patients was 42 years old and the number of prior drainage procedures ranged from 1 to 3. The stent was placed directly into the opening of the cyst after drainage with no other tissue placed into the cyst cavity or opening. The stents are bioabsorbable and were not removed after surgery but were evaluated endoscopically at 2 and 6 weeks after surgery. The patients have been followed for a mean of 14 months after surgery with no evidence of recurrence on endoscopic exam or imaging. No patient had cerebrospinal fluid leak during or after the operation or permanent endocrinopathy.

Conclusion The use of a bioabsorbable steroid eluting stent had no unanticipated consequences and all drainage pathways of all the RCCs remain patent. The use of this technology may decrease recurrence rates in revision or complex cases where patients have extensive scarring of the operative field from prior drainage procedures. Further follow-up of the current cases and study in a larger cohort are warranted.

Keywords

Rathke's cleft cyst - stent placement - skull base - steroid eluting stents - recurrence

Financial Disclosures

The authors have no financial disclosures or conflicts of interest. Of note, none of the authors have or have ever had a consulting or other financial relationship with Intersect ENT.


 

  • References

  • 1 Kuan EC, Yoo F, Chyu J, Bergsneider M, Wang MB. Treatment outcomes of Rathke's cleft cysts managed with marsupialization. J Neurol Surg B Skull Base 2017; 78 (02) 112-115
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Mendelson ZS, Husain Q, Elmoursi S, Svider PF, Eloy JA, Liu JK. Rathke's cleft cyst recurrence after transsphenoidal surgery: a meta-analysis of 1151 cases. J Clin Neurosci 2014; 21 (03) 378-385
    CrossrefPubMedGoogle Scholar
  • 3 Potts MB, Jahangiri A, Lamborn KR, Blevins LS, Kunwar S, Aghi MK. Suprasellar Rathke cleft cysts: clinical presentation and treatment outcomes. Neurosurgery 2011; 69 (05) 1058-1068 , discussion 1068–7
    CrossrefPubMedGoogle Scholar
  • 4 Chotai S, Liu Y, Pan J, Qi S. Characteristics of Rathke's cleft cyst based on cyst location with a primary focus on recurrence after resection. J Neurosurg 2015; 122 (06) 1380-1389
    CrossrefPubMedGoogle Scholar
  • 5 Aho CJ, Liu C, Zelman V, Couldwell WT, Weiss MH. Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg 2005; 102 (02) 189-193
    CrossrefPubMedGoogle Scholar
  • 6 Kinoshita Y, Tominaga A, Usui S. , et al. The long-term recurrence of Rathke's cleft cysts as predicted by histology but not by surgical procedure. J Neurosurg 2016; 125 (04) 1002-1007
    CrossrefPubMedGoogle Scholar
  • 7 Benveniste RJ, King WA, Walsh J, Lee JS, Naidich TP, Post KD. Surgery for Rathke cleft cysts: technical considerations and outcomes. J Neurosurg 2004; 101 (04) 577-584
    CrossrefPubMedGoogle Scholar
  • 8 Tate MC, Jahangiri A, Blevins L, Kunwar S, Aghi MK. Infected Rathke cleft cysts: distinguishing factors and factors predicting recurrence. Neurosurgery 2010; 67 (03) 762-769 , discussion 769
    CrossrefPubMedGoogle Scholar
  • 9 Kasperbauer JL, Orvidas LJ, Atkinson JLD, Abboud CF. Rathke cleft cyst: diagnostic and therapeutic considerations. Laryngoscope 2002; 112 (10) 1836-1839
    CrossrefPubMedGoogle Scholar
  • 10 Higgins DM, Van Gompel JJ, Nippoldt TB, Meyer FB. Symptomatic Rathke cleft cysts: extent of resection and surgical complications. Neurosurg Focus 2011; 31 (01) E2
    PubMedGoogle Scholar
  • 11 Lillehei KO, Widdel L, Astete CA, Wierman ME, Kleinschmidt-DeMasters BK, Kerr JM. Transsphenoidal resection of 82 Rathke cleft cysts: limited value of alcohol cauterization in reducing recurrence rates. J Neurosurg 2011; 114 (02) 310-317
    CrossrefPubMedGoogle Scholar
  • 12 Han SJ, Rolston JD, Jahangiri A, Aghi MK. Rathke's cleft cysts: review of natural history and surgical outcomes. J Neurooncol 2014; 117 (02) 197-203
    CrossrefPubMedGoogle Scholar
  • 13 Murr AH, Smith TL, Hwang PH. , et al. Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. Int Forum Allergy Rhinol 2011; 1 (01) 23-32
    CrossrefPubMedGoogle Scholar
  • 14 Marple BF, Smith TL, Han JK. , et al. Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants. Otolaryngol Head Neck Surg 2012; 146 (06) 1004-1011
    CrossrefPubMedGoogle Scholar
  • 15 Han JK, Marple BF, Smith TL. , et al. Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis. Int Forum Allergy Rhinol 2012; 2 (04) 271-279
    CrossrefPubMedGoogle Scholar
  • 16 Smith TL, Singh A, Luong A. , et al. Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening. Laryngoscope 2016; 126 (12) 2659-2664
    CrossrefPubMedGoogle Scholar
  • 17 Luong A, Ow RA, Singh A. , et al. Safety and effectiveness of a bioabsorbable steroid-releasing implant for the paranasal sinus ostia: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 2017
    PubMedGoogle Scholar
  • 18 Propel (mometasone furoate implant, 370 ug) [package insert]. Intersect ENT, Inc, Menlo Park, CA; 2013 .
    PubMed
  • 19 Byrd J, Fernandez-Miranda J, Wang E, Gardner P, Snyderman C. Cysto-Sphenoid Stenting for Rathke's Cleft Cysts. J Neurol Surg B Skull Base 2014; 75 (01) A173
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Zada G. Rathke cleft cysts: a review of clinical and surgical management. Neurosurg Focus 2011; 31 (01) E1 10.3171/2011.5.FOCUS1183
    PubMedGoogle Scholar
  • 21 Trifanescu R, Stavrinides V, Plaha P. , et al. Outcome in surgically treated Rathke's cleft cysts: long-term monitoring needed. Eur J Endocrinol 2011; 165 (01) 33-37
    CrossrefPubMedGoogle Scholar